X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (23561) 23561
Publication (2315) 2315
Newsletter (522) 522
Book Review (478) 478
Book Chapter (159) 159
Conference Proceeding (41) 41
Dissertation (38) 38
Book / eBook (24) 24
Magazine Article (13) 13
Newspaper Article (13) 13
Reference (8) 8
Data Set (3) 3
Trade Publication Article (3) 3
Paper (2) 2
Transcript (2) 2
Presentation (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (13399) 13399
index medicus (11817) 11817
male (9862) 9862
animals (9322) 9322
angiotensin (6839) 6839
hypertension (6825) 6825
female (6373) 6373
rats (4881) 4881
middle aged (4378) 4378
angiotensin-converting enzyme inhibitors - therapeutic use (3913) 3913
hypertension - drug therapy (3854) 3854
aged (3650) 3650
pharmacology & pharmacy (3507) 3507
peripheral vascular disease (3368) 3368
renin-angiotensin system (3324) 3324
angiotensin ii type 1 receptor blockers - therapeutic use (3246) 3246
cardiac & cardiovascular systems (3217) 3217
angiotensin ii (3202) 3202
blood pressure - drug effects (3048) 3048
blood-pressure (2927) 2927
angiotensin-ii (2911) 2911
antihypertensive agents - therapeutic use (2671) 2671
angiotensin ii type 1 receptor blockers - pharmacology (2625) 2625
blood pressure (2536) 2536
adult (2499) 2499
risk factors (2463) 2463
treatment outcome (2370) 2370
renin-angiotensin system - drug effects (2281) 2281
mice (2185) 2185
heart failure (2167) 2167
oxidative stress (2121) 2121
hypertension - physiopathology (2086) 2086
research (2072) 2072
urology & nephrology (2042) 2042
physiology (1970) 1970
diabetes (1953) 1953
medicine & public health (1948) 1948
mortality (1897) 1897
analysis (1839) 1839
expression (1815) 1815
drug therapy, combination (1777) 1777
rats, sprague-dawley (1749) 1749
drug therapy (1728) 1728
enzymes (1668) 1668
losartan (1651) 1651
tetrazoles - therapeutic use (1586) 1586
angiotensin ii - pharmacology (1567) 1567
renin-angiotensin system - physiology (1490) 1490
care and treatment (1465) 1465
angiotensin-converting enzyme inhibitors - pharmacology (1463) 1463
tetrazoles - pharmacology (1444) 1444
health aspects (1442) 1442
disease models, animal (1434) 1434
physiological aspects (1433) 1433
endocrinology & metabolism (1414) 1414
cardiology (1412) 1412
time factors (1373) 1373
losartan - pharmacology (1333) 1333
valsartan (1316) 1316
internal medicine (1315) 1315
heart-failure (1308) 1308
inflammation (1286) 1286
medicine (1276) 1276
angiotensin receptor antagonists (1263) 1263
angiotensin ii - metabolism (1259) 1259
rodents (1251) 1251
ace inhibitors (1245) 1245
renin (1245) 1245
dose-response relationship, drug (1239) 1239
antihypertensive agents - pharmacology (1238) 1238
receptor, angiotensin, type 1 - metabolism (1226) 1226
heart failure - drug therapy (1222) 1222
article (1198) 1198
hypertension - complications (1194) 1194
rats, wistar (1191) 1191
medicine, general & internal (1159) 1159
fibrosis (1139) 1139
aldosterone (1129) 1129
system (1129) 1129
myocardial-infarction (1125) 1125
cardiovascular (1092) 1092
activation (1070) 1070
disease (1060) 1060
heart (1058) 1058
cell biology (1057) 1057
risk (1056) 1056
cells, cultured (1052) 1052
medicine, research & experimental (1039) 1039
prevention (1015) 1015
aged, 80 and over (1011) 1011
receptor (1007) 1007
benzimidazoles - therapeutic use (1004) 1004
benzimidazoles - pharmacology (1001) 1001
inhibition (981) 981
angiotensin-converting enzyme (976) 976
nephrology (976) 976
adrenergic beta-antagonists - therapeutic use (970) 970
cardiovascular disease (962) 962
angiotensin ii type 1 receptor blockers - administration & dosage (953) 953
signal transduction (928) 928
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (23932) 23932
Japanese (263) 263
German (85) 85
Chinese (54) 54
Spanish (42) 42
French (39) 39
Russian (33) 33
Korean (25) 25
Portuguese (12) 12
Italian (11) 11
Polish (9) 9
Danish (5) 5
Hungarian (5) 5
Czech (4) 4
Swedish (3) 3
Dutch (2) 2
Norwegian (2) 2
Turkish (2) 2
Finnish (1) 1
Hebrew (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature, ISSN 0028-0836, 04/2017, Volume 544, Issue 7650, pp. 327 - 332
Journal Article
Drug Design, Development and Therapy, ISSN 1177-8881, 2019, Volume 13, pp. 385 - 386
Ling-Yue Zhao, Yi-Jun Luo, Jing Zhu Department of Ambulatory Surgery, Shenzhen Nanshan District People's Hospital, Shenzhen, Guangdong 518052, People's... 
PHARMACOLOGY & PHARMACY | CHEMISTRY, MEDICINAL | Hypertension | Double-Blind Method | Angiotensin Receptor Antagonists | Humans | Canrenone | Diabetes Mellitus, Type 2 | Antihypertensive Agents | Hydrochlorothiazide | Clinical trials | Angiotensin II | Diabetes mellitus | Angiotensin | None
Journal Article
Journal Article
Journal Article
Kidney International, ISSN 0085-2538, 07/2014, Volume 86, Issue 1, pp. 75 - 85
Fibrosis is a hallmark of chronic kidney disease, for which there is currently no effective cure. The hormone relaxin is emerging as an effective antifibrotic... 
Smad2 | kidney disease | TGF-β | fibrosis | relaxin | AT2 receptor | KIDNEY-DISEASE | NITRIC-OXIDE SYNTHASE | PROTEIN-KINASE | RESONANCE ENERGY-TRANSFER | FIBROBLASTS | TGF-beta | GROWTH-FACTOR-BETA | AT RECEPTORS | IN-VIVO | UROLOGY & NEPHROLOGY | HYPERTENSIVE-RATS | HORMONE RELAXIN | Relaxin - metabolism | Kidney - pathology | Receptors, G-Protein-Coupled - metabolism | Transforming Growth Factor beta1 - antagonists & inhibitors | Humans | Protein Multimerization | Male | Receptors, Peptide - chemistry | Angiotensin II Type 2 Receptor Blockers - pharmacology | Relaxin - pharmacology | Renal Insufficiency, Chronic - drug therapy | Myofibroblasts - metabolism | Renal Insufficiency, Chronic - metabolism | Kidney - metabolism | Myofibroblasts - pathology | Receptor, Angiotensin, Type 2 - genetics | Kidney - drug effects | Cells, Cultured | Rats | Imidazoles - pharmacology | Recombinant Proteins - pharmacology | Myofibroblasts - drug effects | Rats, Sprague-Dawley | Disease Progression | Mice, Knockout | Renal Insufficiency, Chronic - pathology | Animals | MAP Kinase Signaling System - drug effects | Receptor, Angiotensin, Type 2 - metabolism | Signal Transduction - drug effects | Fibrosis | Mice | Pyridines - pharmacology | Receptor, Angiotensin, Type 2 - deficiency | Receptors, G-Protein-Coupled - chemistry | Receptors, Peptide - metabolism
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2015, Volume 373, Issue 23, pp. 2225 - 2236
Journal Article
Trends in Cardiovascular Medicine, ISSN 1050-1738, 2015, Volume 26, Issue 3, pp. 221 - 228
Abstract Angiotensin II, an important component of renin angiotensin system, is a potent vasopressor and its actions are mostly mediated via angiotensin II... 
Cardiovascular | Heart failure | Hypertension | Renin angiotensin system | Angiotensin receptor blocker | Diabetes mellitus | CARDIAC & CARDIOVASCULAR SYSTEMS | ANTAGONIST | CLINICAL-TRIAL | HEART-FAILURE | DIABETIC-NEPHROPATHY | HYPERTENSIVE PATIENTS | AZILSARTAN MEDOXOMIL | FIMASARTAN | OLMESARTAN | IRBESARTAN | VALSARTAN | Kidney Diseases - physiopathology | Angiotensin II Type 1 Receptor Blockers - adverse effects | Heart Diseases - metabolism | Kidney - pathology | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Receptor, Angiotensin, Type 2 - drug effects | Kidney - metabolism | Drug Interactions | Myocardium - metabolism | Receptor, Angiotensin, Type 1 - drug effects | Drug Therapy, Combination | Kidney Diseases - metabolism | Heart - physiopathology | Kidney - drug effects | Angiotensin II - metabolism | Heart Diseases - physiopathology | Kidney Diseases - drug therapy | Treatment Outcome | Angiotensin II Type 2 Receptor Blockers - adverse effects | Angiotensin II Type 2 Receptor Blockers - therapeutic use | Animals | Receptor, Angiotensin, Type 2 - metabolism | Receptor, Angiotensin, Type 1 - metabolism | Heart - drug effects | Renin-Angiotensin System - drug effects | Heart Diseases - drug therapy | Heart | Pharmacy | Angiotensin converting enzyme | Atherosclerosis | Angiotensin | Physiological aspects | Patient compliance | Studies | Cardiac arrhythmia | Advantages | Cardiomyopathy | Mortality | Inflammation | Diabetes | Kidney diseases | Metabolism
Journal Article
Drug Design, Development and Therapy, ISSN 1177-8881, 2018, Volume 12, pp. 2611 - 2616
Aim: The aim of this study was to evaluate the effects of canrenone compared to hydrochlorothiazide (HCTZ) added to angiotensin II receptor blockers (ARBs) on... 
Canrenone | Hydrochlorothiazide | Type 2 diabetes mellitus | Metabolism | METABOLIC SYNDROME | CHEMISTRY, MEDICINAL | hydrochlorothiazide | HEART-FAILURE | type 2 diabetes mellitus | PHARMACOLOGY & PHARMACY | canrenone | metabolism | Canrenone - therapeutic use | Double-Blind Method | Humans | Middle Aged | Female | Male | Antihypertensive Agents - therapeutic use | Diabetes Mellitus, Type 2 - drug therapy | Angiotensin Receptor Antagonists - therapeutic use | Hydrochlorothiazide - therapeutic use | Hypertension | Type 2 diabetes | Medical research | Diabetics | Corticosteroids | Body weight | Clinical trials | Glycosylated hemoglobin | Triglycerides | Uric acid | Aldosterone | Patient compliance | Angiotensin | Physiological aspects | Medicine, Experimental | Comparative analysis | Renal function | Homeostasis | Lipids | Glucose | Body mass index | Randomization | Hemoglobin | Diuretics | Blood pressure | Angiotensin II | Diabetes mellitus (non-insulin dependent) | Urine | Creatinine | Excretion | Fasting | Parameters | Epidermal growth factor receptors | Diabetes mellitus | Insulin | Patients | Cholesterol | Glomerular filtration rate | Body mass | Body size | Diabetes | Potassium | Family medical history | Metabolic syndrome | Metabolites | Cardiology | Drug dosages | Heart failure | Task forces | Internal medicine | Medicine | Studies | Lipoproteins
Journal Article